Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir

Cancer Gene Therapy

Volumn 7, Issue 6, 2000, Pages 947-953

  Namba, Hiroki ^a   Tagawa, Masatoshi ^b   Miyagawa, Tadashi ^b   Iwadate, Yasuo ^c   Sakiyama, Shigeru ^d  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Division of Pathology   (Japan)

^c CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CHIBA CANCER CENTER   (Japan)

Author keywords

Brain tumor; Bystander effect; Ganciclovir; Gene therapy; Glioma; Herpes simplex virus thymidine kinase

Indexed keywords

THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; GENE THERAPY; GENETIC TRANSDUCTION; GLIOMA; HERPES SIMPLEX VIRUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

ANIMALIA; HERPES; MARTES PENNANTI; SIMPLEXVIRUS;

EID: 0033933977     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700172     Document Type: Article

References (21)

1. Namba H, Tagawa M, Iwadate Y, Kimura M, Sueyoshi K, Sakiyama S. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells. Hum Gene Ther. 1998;9:5-11.
2. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989;7:980-990.
3. Ram Z, Culver KW, Wallbridge S, Blaese RM, Oldfield EH. In situ retroviral-mediated gene transfer for the treatment of brain tumor in rats. Cancer Res. 1993;53:83-88.
4. Namba H, Iwadate Y, Tagawa M, et al. Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging. Hum Gene Ther. 1996;7:1847-1852.
5. McKnight SL. The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. Nucleic Acids Res. 1980;8:5949-5964.
6. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985; 230:1350-1354.
7. Marcel T, Grausz JD. The TMC worldwide gene therapy enrollment report, end 1996. Hum Gene Ther. 1997;8:775-800.
8. Tamura M, Shimizu K, Yamada M, Miyao Y, Hayakawa T, Ikenaka K. Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells. Hum Gene Ther. 1997;8:381-391.
9. Wu JK, Cano WG, Meylaerts SAG, Qi P, Vrionis FD, Cherington V. Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery. 1994;35: 1094-1103.
10. Fick J, Barker FG II, Dazin P, Westphale EM, Beyer EC, Israel MA. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc Natl Acad Sci USA. 1995;92: 11071-11075.
11. Samejima Y, Meruelo D. "Bystander killing" induces apoptosis and is inhibited by forskolin. Gene Ther. 1995;2: 50-58.
12. Vrionis FD, Wu JK, Qi P, Waltzman M, Cherington V, Spray DC. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HS-Vtk) gene is dependent on connexin expression and cell communication via gap junctions. Gene Ther. 1997;4:577-585.
13. Dilber MS, Abedi MR, Christensson B, et al. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res. 1997;57:1523-1528.
14. Baker CF, Billingham RE. Immunologically privileged sites. Adv Immunol. 1977;25:1-54.
15. Kimura M, Tagawa M, Takenaga K, et al. Drug resistance to ganciclovir observed in suicide gene therapy is due to the loss of integrated herpes simplex virus-thymidine kinase gene. Int J Oncol. 1997;10:775-778.
16. Ram Z, Wallbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature growth of 9L gliomas in rats. J Neurosurg. 1994;81:256-260.
17. O'Malley BW Jr, Cope KA, Chen S-H, Li D, Schwartz MR, Woo SLC. Combination gene therapy for oral cancer in a murine model. Cancer Res. 1996;56:1737-1741.
18. Chen S-H, Kosai K-I, Xu B, et al. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res. 1996;56:3758-3762.
19. Santodonato L, Ferrantini M, Gabriele L, et al. Cure of mice with established metastatic Friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-α1 and herpes simplex thymidine kinase followed by ganciclovir. Hum Gene Ther. 1996;7:1-10.
20. Hayashi S, Emi N, Yokoyama I, Namii Y, Uchida K, Takagi H. Inhibition of establishment of hepatic metastasis in mice by combination gene therapy using both herpes simplex virus-thymidine kinase and granulocyte-macrophage colony-stimulating factor genes in murine colon cancer. Cancer Gene Ther. 1997;4:339-344.
21. Coll J-L, Mesnil M, Lefebvre M-F, Lancon A, Favrot MC. Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase/ganciclovir and IL-2 treatment. Gene Ther. 1997;4:1160-1166.